The DOI matches its Crossref record; 242 of the 242 references it cites were found in a registry or an index.
Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers
Open accessAbstract
Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers Camelia R Ban, Stephen M TwiggDiscipline of Medicine and Department of Endocrinology, The University of Sydney and Royal Prince Alfred Hospital, Sydney, New South Wales, 2006, AustraliaAbstract: Diabetes mellitus is characterized by a lack of insulin causing elevated blood glucose, often with associated insulin resistance. Over time, especially in genetically susceptible individuals, such chronic hyperglycemia can cause tissue injury. One pathological response to tissue injury is the development of fibrosis, which involves predominant extracellular matrix (ECM) accumulation. The main factors that regulate ECM in diabetes are thought to be pro-sclerotic cytokines and protease/anti-protease systems. This review will examine the key markers and regulators of tissue fibrosis in diabetes and whether their levels in biological fluids may have clinical utility.Keywords: diabetic complications, extracellular matrix, markers
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–242 of 242
Cooker, L. A., Peterson, D., Rambow, J., Riser, M. L., Riser, R. E., Najmabadi, F., Brigstock, D., & Riser, B. L. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00508.2006 · Cited by 60
Ioachim, E. E., Stefaniotou, M. I., Gorezis, S., Tsanou, E., Psilas, K. G., & Agnantis, N. J. (2005) · European Journal of Ophthalmology · doi:10.1177/112067210501500312 · Cited by 60
Kotajima, N., Kimura, T., Kanda, T., et al. (2000) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(00)00064-7 · Cited by 59
Nakamura, T., Fukui, M., Ebihara, I., Osada, S., Tomino, Y., & Koide, H. (1994) · Kidney & Blood Pressure Research · doi:10.1159/000173864 · Cited by 59
Kim, N. H., Kim, K. B., Kim, D. L., et al. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01200.x · Cited by 59
In situ localization of type III and type IV collagen‐expressing cells in human diabetic nephropathy
Razzaque, M. S., Koji, T., Taguchi, T., Harada, T., & Nakane, P. K. (1994) · The Journal of Pathology · doi:10.1002/path.1711740209 · Cited by 58
High glucose-induced TGF-beta 1 regulates mesangial production of heparan sulfate proteoglycan
Kolm-Litty, V., Sauer, U., Olgemooller, B., & Schleicher, E. D. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.270.5.f812 · Cited by 58
Altered plasma levels of cytokines in patients with ischemic heart disease
Tashiro, H., Shimokawa, H., Yamamoto, K., Momohara, M., Tada, H., & Takeshita, A. (1997) · Coronary Artery Disease · doi:10.1097/00019501-199703000-00004 · Cited by 57
Praga, M. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg284 · Cited by 57
Increased renal production of transforming growth factor-beta1 in patients with type II diabetes
Sharma, K., Ziyadeh, F. N., Alzahabi, B., et al. (1997) · Diabetes · doi:10.2337/diabetes.46.5.854 · Cited by 56
Contribution of PAI-1 in cardiovascular pathology.
Alessi, M., & Juhan-Vague, I. (2004) · PubMed · Cited by 55
Song, W., & Ergul, A. (2006) · Cardiovascular Diabetology · doi:10.1186/1475-2840-5-3 · Cited by 54
Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 and -2 in Type 2 Diabetes
Tayebjee, M. H., Lim, H. S., MacFadyen, R. J., & Lip, G. Y. H. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2049 · Cited by 53
The time has come to target connective tissue growth factor in diabetic complications
Twigg, S. M., & Cooper, M. E. (2004) · Diabetologia · doi:10.1007/s00125-004-1423-6 · Cited by 52
Self-citationTashiro, H., Shimokawa, H., Sadamatu, K., et al. (2002) · Coronary Artery Disease · doi:10.1097/00019501-200205000-00001 · Cited by 51
Liu, Y., Wang, Z., Yin, W., Li, Q., Cai, M., Zhang, C., Junxia, X. I. A. O., Hou, H., Hongguang, L. I., & Xiu-hong, Z. (2007) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.56.11 · Cited by 47
Yagame, M., Kim, Y., Zhu, D., Suzuki, D., Eguchi, K., Nomoto, Y., Sakai, H., Groppoli, T. J., Steffes, M. W., & Mauer, M. S. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000188542 · Cited by 46
Kobayashi, T., Inoue, T., Okada, H., Kikuta, T., Kanno, Y., Nishida, T., Takigawa, M., Sugaya, T., & Suzuki, H. (2005) · Clinical and Experimental Nephrology · doi:10.1007/s10157-005-0347-x · Cited by 46
Expression of angiogenic and fibrogenic factors in proliferative vitreoretinal disorders
El‐Asrar, A. M. A., den Steen, P. E. V., Al-Amro, S. A., Missotten, L., Opdenakker, G., & Geboes, K. J. (2007) · International Ophthalmology · doi:10.1007/s10792-007-9053-x · Cited by 45
Kawasaki, D., Kosugi, K., Waki, H., Yamamoto, K., Tsujino, T., & Masuyama, T. (2007) · Circulation Journal · doi:10.1253/circj.71.524 · Cited by 45
Endothelin‐mediated remodeling in aortas of diabetic rats
Fukuda, G., Khan, Z. A., Barbin, Y. P., Farhangkhoee, H., Tilton, R. G., & Chakrabarti, S. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.527 · Cited by 43
Reduced perlecan expression and accumulation in human carotid atherosclerotic lesions
Tran, P.-K., Agardh, H. E., Tran‐Lundmark, K., Ekstrand, J., Roy, J., Henderson, B., Gabrielsen, A., Hansson, G. K., Swedenborg, J., Paulsson‐Berne, G., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.03.010 · Cited by 42
The Serum Endothelın-1 Level in Steatosıs and NASH, and Its Relatıon wıth Severıty of Lıver Fıbrosıs
Değertekın, B., Özeni̇rler, S., Elbeğ, Ş., & Akyol, G. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9147-8 · Cited by 42
Metalloproteinase-2 and -9 in Diabetic and Nondiabetic Subjects during Acute Coronary Syndromes
Derosa, G., Cicero, A. F. G., Scalise, F., Avanzini, M. A., Tinelli, C., Piccinni, M. N., Peros, E., Geroldi, D., Fogari, E., & D’Angelo, A. (2007) · Endothelium · doi:10.1080/10623320601177064 · Cited by 36
Effect of Glucose on Matrix Metalloproteinase Activity in Mesangial Cells
McLennan, S. V., Yue, D. K., & Turtle, J. R. (1998) · The Nephron journals/Nephron journals · doi:10.1159/000045052 · Cited by 33
Makino, H., Shikata, K., Wieslander, J., Wada, J., Kashihara, N., Yoshioka, K., & Ota, Z. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00276.x · Cited by 33
Azar, S. T., Salti, I., Zantout, M. S., & Major, S. C. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.12.4680 · Cited by 32
Specific heart muscle disease in diabetes mellitus — a functional structural correlation
Das, A. K., Das, J. P., & Chandrasekar, S. (1987) · International Journal of Cardiology · doi:10.1016/0167-5273(87)90080-5 · Cited by 32
Matos, J. P. S., Rodrigues, M., Ismerim, V. L., Boasquevisque, E. M., Genelhu, V. A., & Francischetti, E. A. (2005) · Clinical Nephrology · doi:10.5414/cnp64180 · Cited by 32
Transforming growth factor β1 at clinical onset of Type 1 diabetes mellitus. A pilot study
Flores, L., Näf, S., Hernáez, R., Conget, I., Gomis, R., & Esmatjes, E. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01242.x · Cited by 31
Schneeberger, S. A., Hjelmeland, L. M., Tucker, R. P., & Morse, L. S. (1997) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70861-x · Cited by 30
Katavetin, P., Eiam‐Ong, S., & Suwanwalaikorn, S. (2006) · PubMed · Cited by 30
Nakamura, T., Matsuda, T., Suzuki, Y., Ueda, Y., & Koide, H. (2003) · PubMed · Cited by 30
Edwards, I. J., Wagner, J. D., Vogl-Willis, C. A., Litwak, K. N., & Cefalu, W. T. (2004) · Cardiovascular Diabetology · doi:10.1186/1475-2840-3-6 · Cited by 28
Changes in glomerular extracellular matrices components in diabetic nephropathy
Ikeda, S., Makino, H., Haramoto, T., Shikata, K., Kumagai, I., & Ota, Z. (1991) · Journal of Diabetes and its Complications · doi:10.1016/0891-6632(91)90068-z · Cited by 24
Co-expression of renin???angiotensin system component genes in human atrial tissue
Morgan, K., Wharton, J., Webb, J. C., Keogh, B. E., Smith, P., Taylor, K. M., Oakley, C. M., Polak, J. M., & Cleland, J. G. F. (1994) · Journal of Hypertension · doi:10.1097/00004872-199407030-00003 · Cited by 23
Glomerular expression of tissue inhibitor of metalloproteinase (TIMP-1) in normal and diabetic rats.
Shankland, S. J., Ly, H., Thai, K., & Scholey, J. W. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v7197 · Cited by 23
Ding, Y., Zou, R., Judd, R. L., & Zhong, J. (2006) · Endocrine · doi:10.1385/endo:30:1:121 · Cited by 21
Increased urinary fibronectin excretion in type II diabetic patients with microalbuminuria.
Takahashi, M. (1995) · PubMed · Cited by 19
Arkkila, P. E. T., Rönnemaa, T., Koskinen, P. J., Kantola, I. M., Seppänen, E., & Viikari, J. S. A. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00576.x · Cited by 18
Propeptide of procollagen type I (PIP) and outcomes in decompensated heart failure
Ruiz-Ruiz, F. J., Ruiz-Laiglesia, F., Legarre, P. S., Lasierra-Díaz, P., Flamarique-Pascual, Á., Morales‐Rull, J. L., & Pérez‐Calvo, J. I. (2007) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2006.09.014 · Cited by 16
Wölkart, G., Stessel, H., Saad, Z., Kirchengast, M., & Brünner, F. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706772 · Cited by 16
Cited by
Diabetic cardiomyopathy, causes and effects
Boudina, S., & Abel, E. D. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9131-7 · Cited by 728
Skeletal muscle: A review of molecular structure and function, in health and disease
Mukund, K., & Subramaniam, S. (2020) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1462 · Cited by 664
The Role of IL-6 in Skin Fibrosis and Cutaneous Wound Healing
Johnson, B. Z., Stevenson, A. W., Prêle, C. M., Fear, M. W., & Wood, F. M. (2020) · Biomedicines · doi:10.3390/biomedicines8050101 · Cited by 529
The Role of Oxidative Stress in the Pathophysiology of Gestational Diabetes Mellitus
Lappas, M., Hiden, U., Desoye, G., Froehlich, J., Mouzon, S. H.-D., & Jawerbaum, A. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3765 · Cited by 442
The role of triterpenes in the management of diabetes mellitus and its complications
Nazaruk, J., & Borzym-Kluczyk, M. (2015) · Phytochemistry Reviews · doi:10.1007/s11101-014-9369-x · Cited by 282
Metadata
- Authors
- Twigg, S.
- Venue
- Vascular Health and Risk Management
- Publisher
- Informa UK Limited
- Published
- 2008-06
- Volume
- Volume 4
- Issue
- 3
- Pages
- 575-596
- ISSN
- 1176-6344 (ISSN-L)
- 1178-2048
- OpenAlex
- W1653800962
- Cited by
- 286
- References
- 242
- FWCI
- 10.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.